Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-21

Clinical Trial Update: Study Regarding the Incidence of Anti-platelet Factor 4-antibodies in Patients Aged 18 to 60 Years With Spontaneous or Infection- or Vaccine-associated or Recurrent Venous and/or Arterial Thrombosis

View source ↗

Summary

A recruiting clinical trial is evaluating the incidence of anti-platelet factor 4 antibodies in adults aged 18 to 60 with spontaneous, infection- or vaccine-ass…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Cardioangiologisches Centrum Bethanien | Conditions: Arterial or Venous Thrombosis | Status: RECRUITING